This history proves you are not looking for an easy way out
Summary of Key Considerations MEDVi operates as a telehealth platform facilitating access to GLP-1 weight loss medications through independent licensed clinicians and partner pharmacies
It is an unlicensed, unapproved substance globally
GLP-1 users may differ from nonusers in ways that are not fully captured, such as socioeconomic status, health behaviors, disease severity, medication adherence, or access to care." Lakkis notes that the study also did not report how much weight participants lost, making it difficult to determine how much of the benefit may have been driven by weight reduction itself
Keep in mind that microdosing is not a studied protocol
How Healthon Clinicians Tailor Dosing, Nutrition, And Labs At Healthon, we believe that successful weight management is not one-size-fits-all